Wazir, N., & Rehman, S. U. (2022). Efficacy and Safety of Empagliflozin as Add-On Therapy in Patients of Type-2 Diabetes Mellitus. Journal of Gandhara Medical and Dental Science, 9(1), 24–27. https://doi.org/10.37762/jgmds.9-1.173